SKIA

[PRIVATE]

Service & Cobot Robotics · HQ: Seoul, South Korea · Est. 2018 · 2 models registered · 1 deployments

New deployment

As of Sep 2026, DEPLOY verifies SKIA: 2 models. 2 sources back the record.

Ownership

PRIVATE

Capital / Funding

Undisclosed

Headquarters

Seoul, South Korea

IP / Patents

Undisclosed

Platform Models

2

Audited Incidents

0

Overview

South Korean medtech company developing tablet-based augmented reality (AR) surgical guidance systems. Its flagship SKIA HEAD platform converts preoperative CT/MRI imaging into 3D anatomical reconstructions projected onto the patient's body in real time, powered by medical-grade Structure Sensors. The company received FDA 510(k) clearance in May 2026 and is expanding to the US market through a hardware partnership with Structure. SKIA's broader portfolio includes SKIA Body (used in 80+ hernia surgeries in India), SKIA Face, and SKIA Breast (in confirmatory clinical trials at Seoul National University, Yonsei Severance, and Ewha Womans University Hospital).

Audited Posture AssessmentPeer Percentile: 56.8%

Clean safety record across 1 verified deployment. Limited public funding data for capital position assessment.

  • SURGICAL

Key Facts

FDA 510(k)K260723 cleared July 9, 2026 — AR surgical guidance system
TypeTraditional 510(k)
ProductSKIA HEAD — tablet-based AR surgical guidance system
FDA clearance510(k) cleared (K251577) — AR-guided surgical navigation
TechnologyAugmented reality projects 3D anatomical models onto patient body during surgery
US expansionPartnership with Structure for US market entry

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for SKIA.

Leadership & Founders

1 entry

Current Program Leadership & Executives

Jong-Myoung Leesecondary-verified

CEO

Partnerships & Commercial Deployments

2 entries
Total Tracked2
Operating0
Announced1
Concluded0

Key Recurring Partners

AWS1 · 1× joint · 976 total

Recent Verified Partnerships

  • SKIA x StructureMay 29, 2026

    MOST RECENT · SKIA x Structure · 2026-05-29 · with Structure · JUST ANNOUNCED

Platform Models

2 entries

Deployments

1 entry

Sectors & Applications

1 entry

FAQ

11 entries
What is SKIA?

South Korean medtech company developing tablet-based augmented reality (AR) surgical guidance systems. Its flagship SKIA HEAD platform converts preoperative CT/MRI imaging into 3D anatomical reconstructions projected onto the patient's body in real time, powered by medical-grade Structure Sensors. The company received FDA 510(k) clearance in May 2026 and is expanding to the US market through a hardware partnership with Structure. SKIA's broader portfolio includes SKIA Body (used in 80+ hernia surgeries in India), SKIA Face, and SKIA Breast (in confirmatory clinical trials at Seoul National University, Yonsei Severance, and Ewha Womans University Hospital).

What does SKIA make?

SKIA has 2 robot models on the DEPLOY registry: SKIA Body, SKIA HEAD (SKIA builds physical robots).

Is SKIA publicly traded?

No. SKIA is privately held and not publicly traded, per the DEPLOY registry.

Who is the CEO of SKIA?

Jong-Myoung Lee is the ceo of SKIA, per the DEPLOY registry.

How can I invest in SKIA?

SKIA is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today.

Where is SKIA headquartered?

SKIA is headquartered in Seoul, South Korea.

Who owns SKIA?

SKIA is privately held; ownership sits with its founders and private investors.

Where does SKIA operate robots?

SKIA is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is SKIA a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, SKIA ranks in roughly the top 44% of companies tracked by the registry.

When was SKIA founded?

SKIA was founded in 2018.

Is SKIA safe?

SKIA has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.